Sponsored Links
| Data Presented At Two Global Medical Congresses Reinforce Significant Benefit Of Enbrel(R) For Patients With Chronic Inflammatory Conditions |
 |
 |
 |
| Medical News - Eczema and Psoriasis | |||
|
Pfizer (NYSE: PFE) today announced new results from multiple studies of ENBREL (etanercept), further expanding the body of evidence supporting the efficacy and safety profile of ENBREL, the most prescribed biologic by rheumatologists worldwide... Read more: Eczema / Psoriasis News From Medical News Today
|